VANCOUVER, British Columbia,
June 11, 2018 /CNW/ --
Zecotek Photonics Inc. (TSX-V: ZMS) (Frankfurt: W1I.F)
(OTCPK: ZMSPF), a developer of leading-edge photonics technologies
for healthcare, industrial and scientific markets, is pleased to
announce that it is working closely with a tier 1, healthcare OEM
based in Europe to assure quality
control protocols within its new Lutetium Fine Silicate (LFS)
scintillation crystals manufacturing facility in Shanghai. The healthcare OEM originally
ordered LFS crystals for a new line of high resolution positron
emission tomography PET/CT medical imaging devices in October 2017. After testing and qualifying
Zecotek's arrays produced in China, the healthcare OEM has since made a
larger scale order of arrays for final design. The OEM has also
deployed personnel to assist with the setup of the crystal growing
facility, with higher production volumes to commence later this
year.
"We have worked closely with our largest customers to ensure
that the LFS scintillation crystals produced in our Shanghai facility meet their exacting
standards," said Dr. A.F. Zerrouk, Chairman, President, and CEO of
Zecotek Photonics Inc. "It is a very exciting time for our Company
as we look to begin production of our patented LFS crystals within
the next three weeks as site preparation and renovations are now
complete. We have benefited from working closely with our customers
and specifically the European healthcare OEM, in the setting up of
quality control protocols to meet the highest industry standards.
We are looking forward to supplying our crystals to the
aforementioned European customer as well as other large OEM
customers, building high resolution PET machines."
By establishing its own crystal manufacturing facility in
Shanghai, the Company is
strategically positioning itself to become a dominant supplier.
Scintillation crystals play a vital role in fundamental in
healthcare, science, industrial and security applications, where
they are used to convert high-energy photons into visible light.
Zecotek's patented LFS scintillation material with all its variants
are known to have superior operating attributes and were developed
specifically for use in medical imaging systems, high-energy
physics experiments, and other applications.
Zecotek has attracted Chinese and international medical device
OEMs, including the tier 1 European OEM adopting LFS crystals, to
use the fast and bright LFS scintillation crystals in new
generation PET and PET/CT medical scanning devices. New and more
efficient readout systems, combined with faster and brighter
crystals and more sensitive photo detectors, have created the
technological environment where the new devices are being readied
for the medical markets with far superior operating systems than
current devices being used in hospitals today. Medical officials
around the world are seeking faster, higher resolution scanning
devices as aging populations place greater demands on their
respective healthcare systems.
Zecotek's patented (US patent No. 7,132,060) LFS series of
scintillation crystals are characterized by their high light yields
and ultra-fast decay times which will produce quicker, more
detailed images and diagnoses, resulting in faster patient
throughput and improved patient outcomes. The LFS crystals cover a
wide range of emission wavelengths which can be tailored to match
the spectral sensitivity of various photo detectors including
Zecotek's own solid-state MAPD/T photo detector arrays.
Zecotek's manufacturing process uses the Czochralski method with
proprietary modifications and results in the growth of very
large-diameter boules with uniform properties and without cracking,
resulting in high element output and lower unit costs. The
crystal manufacturing facility will also provide cutting and
polishing producing high quality value-added finished
products.
About Zecotek
Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I; OTCPK: ZMSPF) is a photonics
technology company developing high-performance scintillation
crystals, photo detectors, positron emission tomography scanning
technologies, 3D auto-stereoscopic displays, 3D metal printing, and
lasers for applications in medical, high-tech and industrial
sectors. Founded in 2004, Zecotek operates three divisions:
Imaging Systems, Optronics Systems and 3D Display Systems with labs
located in Canada, Korea,
Russia, Singapore and U.S.A. The management team is focused on
building shareholder value by commercializing over 50 patented and
patent pending novel photonic technologies directly and through
strategic alliances with Hamamatsu Photonics (Japan), the European Organization for Nuclear
Research (Switzerland), Shanghai
EBO Optoelectronics Technology Co. (China), NuCare Medical Systems (South Korea), the University of Washington (United States), and National NanoFab Center
(South Korea). For more
information visit www.zecotek.com and follow @zecotek on
Twitter.
This press release may contain forward-looking statements
that are based on management's expectations, estimates, projections
and assumptions. These statements are not guarantees of future
performance and involve certain risks and uncertainties, which are
difficult to predict. Therefore, actual future results and trends
may differ materially from what may have been stated.
Neither the TSX Venture Exchange nor its Regulation Service
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of the content of this news release. If you would like to
receive news from Zecotek in the future please visit the corporate
website at www.zecotek.com.
For Additional Information Please Contact:
Zecotek Photonics Inc.
Michael Minder
T: (604) 783-8291
ir@zecotek.com
View original
content:http://www.prnewswire.com/news-releases/zecoteks-working-closely-with-european-healthcare-oem-as-it-prepares-to-open-its-lfs-crystal-manufacturing-facility-300663912.html
SOURCE Zecotek Photonics Inc
